108 results on '"Mueller, Nicolas J."'
Search Results
2. Invasive Aspergillosis in Liver Transplant Recipients in The Current Era
3. Bcl-2, JAK and mTOR Inhibitors
4. Emergence of novel circoviruses in humans and pigs and their possible importance for xenotransplantation and blood transfusions
5. Detection of Scedosporium spp.: Colonizer or pathogen? A retrospective analysis of clinical significance and management in a large tertiary center
6. Changing Definition of Immunosuppression: Targeted Therapies and Resulting Emerging Infections and Their Prevention
7. Mycoplasma and Ureaplasma Infections in Transplantation: A Big Impact Despite the Lack of a Cell Wall
8. Treatment and Prevention of Herpesvirus Infections in the Immunocompromised Host
9. Adjunctive glucocorticoid therapy for Pneumocystis jirovecii pneumonia in solid organ transplant recipients: A multicenter cohort, 2015-2020
10. Changing Definition of Immunosuppression: Targeted Therapies and Resulting Emerging Infections and Their Prevention
11. Goals to score: The need for a minimum reporting dataset in studies of infection events in immunocompromised patients
12. XENOZOONOSIS IN XENOTRANSPLANTATION: CLINICAL CHALLENGES
13. Consensus position statement on advancing the standardised reporting of infection events in immunocompromised patients
14. ‘Which trial do we need? Culture of preservation fluid in abdominal organ transplant recipients’ Author's reply
15. The Epidemiology of Infection in Solid Organ Transplant Recipients: A Practical Timeline
16. Which trial do we need? Culture of preservation fluid in abdominal-organ transplant recipients
17. Immunogenicity, Efficacy, and Safety of High-Dose Trivalent vs. MF59-Adjuvanted Trivalent vs. Standard-Dose Non-Adjuvanted Quadrivalent Influenza Vaccine in Solid Organ Transplant Recipients: A Randomised Clinical Trial. The STOP-FLU Trial
18. Epidemiology and outcomes of bone and joint infections in solid organ transplant recipients
19. Antibody response to a third SARS‐CoV‐2 vaccine dose in recipients of an allogeneic haematopoietic cell transplantation
20. Porcine cytomegalovirus/porcine roseolovirus (PCMV/PRV): A threat for xenotransplantation?
21. Elimination of Herpes Simplex Virus-2 and Epstein-Barr Virus With Seraph 100 Microbind Affinity Blood Filter and Therapeutic Plasma Exchange: An Explorative Study in a Patient With Acute Liver Failure
22. Determinants of antibody response to severe acute respiratory syndrome coronavirus 2 mRNA vaccines in people with HIV
23. Central nervous system infections in solid organ transplant recipients: Results from the Swiss Transplant Cohort Study
24. Porcine cytomegalovirus: A very unwelcome stowaway
25. WITHDRAWN: Incidence and outcome of surgical site infections in thoracic-organ transplant recipients registered in the Swiss Transplant Cohort Study
26. Safety Evaluation of a Medical Congress Held During the COVID-19 Pandemic—A Prospective Cohort
27. Epidemiology and outcomes of medically attended and microbiologically confirmed bacterial foodborne infections in solid organ transplant recipients
28. Cohort profile: The Swiss Transplant Cohort Study (STCS): A nationwide longitudinal cohort study of all solid organ recipients in Switzerland
29. Antibody Response to Sars-Cov-2 Vaccination in Patients Following Allogeneic Hematopoietic Cell Transplantation
30. Trimethoprim/sulfamethoxazole for nocardiosis in solid organ transplant recipients: Real‐life data from a multicentre retrospective study
31. Sources and prevention of graft infection during long‐term ex situ liver perfusion
32. Burden, epidemiology, and outcomes of microbiologically confirmed respiratory viral infections in solid organ transplant recipients: a nationwide, multi-season prospective cohort study
33. Safety evaluation of a medical congress held during the COVID-19 pandemic – a prospective cohort
34. Pneumocystis jiroveci Pneumonia: Prophylaxis and Therapy
35. First experience of SARS-CoV-2 infections in solid organ transplant recipients in the Swiss Transplant Cohort Study
36. Varicella Zoster Virus in Inflammatory Bowel Disease Patients: What Every Gastroenterologist Should Know
37. Optimal Treatment Duration of Pseudomonas aeruginosa Infections in Allogeneic Hematopoietic Cell Transplant Recipients
38. Reply to Sultan et al
39. Long-Term Follow-Up of Antibody Titers Against Measles, Mumps, and Rubella in Recipients of Allogenic Hematopoietic Cell Transplantation
40. Heart or lung transplant outcomes in HIV-infected recipients
41. Imaging patterns of Pneumocystis jirovecii pneumonia in HIV-positive and renal transplant patients – a multicentre study
42. Multicenter Population Pharmacokinetic Study of Colistimethate Sodium and Colistin Dosed as in Normal Renal Function in Patients on Continuous Renal Replacement Therapy
43. Efficient Human Cytomegalovirus Replication in Primary Endothelial Cells Is SOCS3 Dependent
44. Genetic immune and inflammatory markers associated with diabetes in solid organ transplant recipients
45. Metagenomic Virome Sequencing in Living Donor and Recipient Kidney Transplant Pairs Revealed JC Polyomavirus Transmission
46. Efficacy of selective digestive decontamination in patients with multiple myeloma undergoing high-dose chemotherapy and autologous stem cell transplantation
47. Toxoplasmosis in Transplant Recipients, Europe, 2010–2014
48. Allogeneic hematopoietic cell transplantation in patients with GATA2 deficiency—a case report and comprehensive review of the literature
49. No neurocognitive advantage for immediate antiretroviral treatment in adults with greater than 500 CD4+ T-cell counts
50. Hohe Inzidenz von Varizella- Zoster-Meningoenzephalitiden in Graubünden im Jahr 2014
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.